These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2890782)

  • 21. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites.
    Pfeiffer A; Herz A
    Life Sci; 1982 Sep 20-27; 31(12-13):1355-8. PubMed ID: 6128658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion.
    Carr KD; Bonnet KA; Simon EJ
    Brain Res; 1982 Aug; 245(2):389-93. PubMed ID: 6289969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynorphin interaction at the kappa-opiate site.
    Huidobro-Toro JP; Yoshimura K; Lee NM; Loh HH; Way EL
    Eur J Pharmacol; 1981 Jun; 72(2-3):265-6. PubMed ID: 6113976
    [No Abstract]   [Full Text] [Related]  

  • 25. CNS blockade of acoustic stress-induced gastric motor inhibition by kappa-opiate agonists in dogs.
    Gue M; Honde C; Pascaud X; Junien JL; Alvinerie M; Bueno L
    Am J Physiol; 1988 Jun; 254(6 Pt 1):G802-7. PubMed ID: 2897797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro.
    Bicknell RJ; Chapman C; Leng G
    Neuroendocrinology; 1985 Aug; 41(2):142-8. PubMed ID: 2864649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M; Kubota A; Iwama T; Wada T; Yasui M; Fujibayashi K; Takagi H
    Life Sci; 1983; 33 Suppl 1():689-92. PubMed ID: 6141508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord.
    Tung AS; Yaksh TL
    Brain Res; 1982 Sep; 247(1):75-83. PubMed ID: 6127147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
    Pairet M; Ruckebusch Y
    Life Sci; 1984 Oct; 35(16):1653-8. PubMed ID: 6148681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ethylketocyclazocine on adrenergic transmission in the isolated perfused cat spleen.
    Gaddis RR; Dixon WR
    Pharmacology; 1985; 30(4):205-14. PubMed ID: 2986185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of kappa opioid receptors in the rabbit ear artery.
    Berzetei IP; Fong A; Yamamura HI; Duckles SP
    Eur J Pharmacol; 1988 Jul; 151(3):449-55. PubMed ID: 2905660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain.
    Periyasamy S; Hoss W
    Life Sci; 1990; 47(3):219-25. PubMed ID: 1975082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.
    Valette A; Tafani M; Porthe G; Pontonnier G; Cros J
    Life Sci; 1983; 33 Suppl 1():523-6. PubMed ID: 6141498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus.
    Dewar D; Jenner P; Marsden CD
    Neuroscience; 1985 May; 15(1):41-6. PubMed ID: 2989729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.